Drug recall · October 2, 2019
minolira recall
Why: Failed Dissolution Specifications:
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
minolira (minocycline hydrochloride) extended-release tablets 135 mg* Physician Sample Not for Sale 5 Tablets, Rx Only, Mfg by: Dr. Reddy's Laboratories Limited, FTO-SEZ, Process Unit-01 Devunipalavalasa Village Srikakulam (District) Andhra Pradesh, INDIA. Manufactured for: EPI Health, LLC 134 Columbus St. Charleston, SC 29403 USA. NDC 71403-102-05.
- Lots / codes
Lot# T900093, Exp 11/2020
- Quantity
- 1,626 5-count bottles
- Company
- EPI Health, LLC, Charleston, SC
- Distribution
- Firm recalling only from EPI Field Representatives.
- Initiated
- August 26, 2019 · Voluntary: Firm initiated
- Classified
- October 2, 2019
- Reported
- October 2, 2019
- Ended
- August 18, 2021
- How notified
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Minocycline
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.